Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-28

Clinical Trial Update: Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating topical oxybutynin for hyperhidrosis to assess local versus systemic effects. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin topical (oxybutynin)

Snippet

Sponsor: Samantha Rodrigues Camargo Neves de Moura | Conditions: Hyperhidrosis, Oxybutynin | Phase 2 | Status: RECRUITING